Psychedelics, Plasticity, Critical Periods, Social Learning, Psilocybin, MDMA, Ketamine | Gül Dölen

Nick talks to Gül Dölen, MD, PhD., a neuroscientist at Johns Hopkins University whose lab studies social behavior, synaptic plasticity, psychedelics & evolution. They discuss: What drugs like LSD, psilocybin, ketamine, MDMA, and ibogaine have in common in terms of their molecular effects in the brain; why Dr. Gül Dölen believes all of these drugs can be described as "psychedelics"; the relationship between psychedelics and neuroplasticity vs. metaplasticity; how addictive drugs are similar to and different from psychedelics; social reward learning in rodents & critical periods of plasticity; the subjective effects of psychedelics; novel psychedelic drug development; human social behavior, mental health, and psychiatry; and more.

LEARN MORE & SUPPURT M&M:
All M&M content, including podcast episodes & written content, is available on Substack. I mainly respond to questions & comments on that channel:
[ https://mindandmatter.substack.com ]

If you enjoy M&M content and want to provide further support, read this:
[ https://mindandmatter.substack.com/p/... ]

ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.